Amicare Sp. z o.o. S.K.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis2 trials

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• Faes Farma S.A.1 trial
• Landos Biopharma Inc.1 trial

Closed trials

• Completed

  A randomised, double-blind, double-dummy, multicentre, phase III, non inferiority trial of an oral mesalazine formulation in patients with active mild to moderate ulcerative colitis for the induction of remission.

  NCT06176560· Phase 3· Faes Farma S.A.· Source

• Completed

  Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Participants with Moderate to Severe Ulcerative Colitis

  2022-503005-38-00· Phase 2· Landos Biopharma Inc.· Source